NCT00372307View on ClinicalTrials.gov

Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

November 30, 2004

Conditions
Vitiligo Vulgaris
Interventions
DRUG

Application of pimecrolimus

Trial Locations (1)

9000

University Hospital Ghent, Ghent

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University Hospital, Ghent

OTHER

NCT00372307 - Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris | Biotech Hunter | Biotech Hunter